Is cytokine-release syndrome the cause of rituximab treatment-related infusion reactions in children with nephrotic syndrome? Impact of anti-rituximab antibodies

被引:4
|
作者
Fujinaga, Shuichiro [1 ]
Nishino, Tomohiko [1 ]
机构
[1] Saitama Childrens Med Ctr, Div Nephrol, Chuo Ku, 1-2 Shintoshin, Saitama, Saitama 3308777, Japan
关键词
D O I
10.1007/s00467-018-3960-0
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:1097 / 1098
页数:2
相关论文
共 50 条
  • [31] Does rituximab induce hypogammaglobulinemia in the treatment of children with steroid dependent idiopathic nephrotic syndrome?
    Delbe-Bertin, L.
    Ulinsk, T.
    PEDIATRIC NEPHROLOGY, 2011, 26 (09) : 1675 - 1676
  • [32] Adverse events following rituximab infusion in children with nephrotic syndrome: a systematic review and meta-analysis
    Xue, Yuanxin
    Lee, James
    Chung, Jason
    Robinson, Cal
    Bamhraz, Abdulaziz A.
    Ewusie, Joycelyne E.
    Thabane, Lehana
    Sinha, Rajiv
    Sanger, Stephanie
    Chanchlani, Rahul
    PEDIATRIC NEPHROLOGY, 2023, 38 (07) : 2473 - 2474
  • [33] Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome
    Fujinaga, Shuichiro
    Tomii, Yuji
    PEDIATRIC NEPHROLOGY, 2019, 34 (07) : 1303 - 1304
  • [34] Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome
    Shuichiro Fujinaga
    Yuji Tomii
    Pediatric Nephrology, 2019, 34 : 1303 - 1304
  • [35] Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome
    Sinha, Rajiv
    Marlais, Matko
    Sarkar, Subhankar
    Obukhova, Varvara
    Lucchetti, Laura
    Vasudevan, Anil
    Chacon Jaimes, Diana Carolina
    Weaver, Donald J., Jr.
    Stanczyk, Malgorzata
    Lopez-Gonzalez, Mercedes
    Schaefer, Franz
    Tullus, Kjell
    PEDIATRIC RESEARCH, 2022, 92 (01) : 3 - 5
  • [36] Impact of COVID-19 pandemic on use of rituximab among children with difficult nephrotic syndrome
    Rajiv Sinha
    Matko Marlais
    Subhankar Sarkar
    Varvara Obukhova
    Laura Lucchetti
    Anil Vasudevan
    Diana Carolina Chacon Jaimes
    Donald J. Weaver
    Małgorzata Stańczyk
    Mercedes Lopez-Gonzalez
    Franz Schaefer
    Kjell Tullus
    Pediatric Research, 2022, 92 : 3 - 5
  • [37] The Efficacy and Safety of Rituximab in the Treatment of Steroid-dependent or Frequently Relapsing Nephrotic Syndrome in Children
    Su, Q. X.
    Qi, X. J.
    Shen, Y. N.
    Dou, Z. Y.
    Rong, Z. H.
    Zhao, X.
    Yu, B.
    Wang, Y. X.
    Wang, X. L.
    HONG KONG JOURNAL OF PAEDIATRICS, 2022, 27 (04) : 241 - 248
  • [38] Rituximab versus cyclophosphamide for the treatment of children with steroid resistance nephrotic syndrome; a clinical trial study
    Sepahi, Mohsen Akhavan
    Farahani, Najmeh
    Razavi, Mohammad Reza
    Heydari, Hossein
    Arsang-Jang, Shahram
    IMMUNOPATHOLOGIA PERSA, 2019, 5 (02):
  • [39] Response to "Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome"
    Ulinski, Tim
    Delbet, Jean Daniel
    PEDIATRIC NEPHROLOGY, 2019, 34 (07) : 1305 - 1306
  • [40] Response to “Predictors of rituximab-related neutropenia in Japanese children with steroid-dependent nephrotic syndrome”
    Tim Ulinski
    Jean Daniel Delbet
    Pediatric Nephrology, 2019, 34 : 1305 - 1306